Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
4 hedge funds and large institutions have $751K invested in Viking Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
15% less capital invested
Capital invested by funds: $879K → $751K (-$128K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$11K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
1
Park West Asset Management
San Francisco,
California
| $511K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $181K | +$73.4K | +12,459 | +58% |
|
|
3
William Blair & Company
Chicago,
Illinois
| $39K | -$11K | -1,870 | -21% |
|
|
4
UBS Group
Zurich,
Switzerland
| $20K | -$2.36K | -400 | -10% |
|
VKTXW Hedge Fund Activity: Q3 2019 in Review
4 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q3 2019, worth a combined $751K — down 15% from $879K a quarter earlier.
Fund positioning in VKTXW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $73.4K. The largest seller was William Blair & Company, cutting an estimated $11K.
- 4 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $751K of Viking Therapeutics, Inc. stock for Q3 2019, down 15% quarter-over-quarter.
- 0 funds opened new Viking Therapeutics, Inc. positions in Q3 2019 and 0 closed out.
- The largest Viking Therapeutics, Inc. buyer in Q3 2019 was Susquehanna International Group, an estimated $73.4K added.
- The largest Viking Therapeutics, Inc. seller in Q3 2019 was William Blair & Company, an estimated $11K sold.
Based on aggregated 13F filings for Q3 2019.